Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by ALK Positive Lung Cancer Treatment Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global ALK Positive Lung Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Crizotinib
    • 1.4.3 Alectinib
    • 1.4.4 Ceritinib
    • 1.4.5 Brigatinib
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global ALK Positive Lung Cancer Treatment Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): ALK Positive Lung Cancer Treatment Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the ALK Positive Lung Cancer Treatment Industry
      • 1.6.1.1 ALK Positive Lung Cancer Treatment Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and ALK Positive Lung Cancer Treatment Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for ALK Positive Lung Cancer Treatment Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 ALK Positive Lung Cancer Treatment Market Perspective (2015-2026)
  • 2.2 ALK Positive Lung Cancer Treatment Growth Trends by Regions
    • 2.2.1 ALK Positive Lung Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 ALK Positive Lung Cancer Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 ALK Positive Lung Cancer Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 ALK Positive Lung Cancer Treatment Market Growth Strategy
    • 2.3.6 Primary Interviews with Key ALK Positive Lung Cancer Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top ALK Positive Lung Cancer Treatment Players by Market Size
    • 3.1.1 Global Top ALK Positive Lung Cancer Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global ALK Positive Lung Cancer Treatment Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global ALK Positive Lung Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio
    • 3.2.1 Global ALK Positive Lung Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by ALK Positive Lung Cancer Treatment Revenue in 2019
  • 3.3 ALK Positive Lung Cancer Treatment Key Players Head office and Area Served
  • 3.4 Key Players ALK Positive Lung Cancer Treatment Product Solution and Service
  • 3.5 Date of Enter into ALK Positive Lung Cancer Treatment Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global ALK Positive Lung Cancer Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Type (2021-2026)

5 ALK Positive Lung Cancer Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)
  • 5.2 Global ALK Positive Lung Cancer Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 6.2 ALK Positive Lung Cancer Treatment Key Players in North America (2019-2020)
  • 6.3 North America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 6.4 North America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 7.2 ALK Positive Lung Cancer Treatment Key Players in Europe (2019-2020)
  • 7.3 Europe ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 7.4 Europe ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

8 China

  • 8.1 China ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 8.2 ALK Positive Lung Cancer Treatment Key Players in China (2019-2020)
  • 8.3 China ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 8.4 China ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 9.2 ALK Positive Lung Cancer Treatment Key Players in Japan (2019-2020)
  • 9.3 Japan ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 9.4 Japan ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 10.2 ALK Positive Lung Cancer Treatment Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 10.4 Southeast Asia ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

11 India

  • 11.1 India ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 11.2 ALK Positive Lung Cancer Treatment Key Players in India (2019-2020)
  • 11.3 India ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 11.4 India ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America ALK Positive Lung Cancer Treatment Market Size (2015-2020)
  • 12.2 ALK Positive Lung Cancer Treatment Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America ALK Positive Lung Cancer Treatment Market Size by Type (2015-2020)
  • 12.4 Central & South America ALK Positive Lung Cancer Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 F. Hoffmann-La Roche
    • 13.1.1 F. Hoffmann-La Roche Company Details
    • 13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
    • 13.1.3 F. Hoffmann-La Roche ALK Positive Lung Cancer Treatment Introduction
    • 13.1.4 F. Hoffmann-La Roche Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020))
    • 13.1.5 F. Hoffmann-La Roche Recent Development
  • 13.2 Pfizer
    • 13.2.1 Pfizer Company Details
    • 13.2.2 Pfizer Business Overview and Its Total Revenue
    • 13.2.3 Pfizer ALK Positive Lung Cancer Treatment Introduction
    • 13.2.4 Pfizer Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.2.5 Pfizer Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview and Its Total Revenue
    • 13.3.3 Novartis ALK Positive Lung Cancer Treatment Introduction
    • 13.3.4 Novartis Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 TP Therapeutics
    • 13.4.1 TP Therapeutics Company Details
    • 13.4.2 TP Therapeutics Business Overview and Its Total Revenue
    • 13.4.3 TP Therapeutics ALK Positive Lung Cancer Treatment Introduction
    • 13.4.4 TP Therapeutics Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.4.5 TP Therapeutics Recent Development
  • 13.5 Bristol-Myers Squibb
    • 13.5.1 Bristol-Myers Squibb Company Details
    • 13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.5.3 Bristol-Myers Squibb ALK Positive Lung Cancer Treatment Introduction
    • 13.5.4 Bristol-Myers Squibb Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.5.5 Bristol-Myers Squibb Recent Development
  • 13.6 Eli Lilly and Company
    • 13.6.1 Eli Lilly and Company Company Details
    • 13.6.2 Eli Lilly and Company Business Overview and Its Total Revenue
    • 13.6.3 Eli Lilly and Company ALK Positive Lung Cancer Treatment Introduction
    • 13.6.4 Eli Lilly and Company Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.6.5 Eli Lilly and Company Recent Development
  • 13.7 Takeda
    • 13.7.1 Takeda Company Details
    • 13.7.2 Takeda Business Overview and Its Total Revenue
    • 13.7.3 Takeda ALK Positive Lung Cancer Treatment Introduction
    • 13.7.4 Takeda Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.7.5 Takeda Recent Development
  • 13.8 Beacon Pharma
    • 13.8.1 Beacon Pharma Company Details
    • 13.8.2 Beacon Pharma Business Overview and Its Total Revenue
    • 13.8.3 Beacon Pharma ALK Positive Lung Cancer Treatment Introduction
    • 13.8.4 Beacon Pharma Revenue in ALK Positive Lung Cancer Treatment Business (2015-2020)
    • 13.8.5 Beacon Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global ALK Positive Lung Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the ALK Positive Lung Cancer Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    F. Hoffmann-La Roche
    Pfizer
    Novartis
    TP Therapeutics
    Bristol-Myers Squibb
    Eli Lilly and Company
    Takeda
    Beacon Pharma

    Market segment by Type, the product can be split into
    Crizotinib
    Alectinib
    Ceritinib
    Brigatinib
    Other
    Market segment by Application, split into
    Hospital
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global ALK Positive Lung Cancer Treatment status, future forecast, growth opportunity, key market and key players.
    To present the ALK Positive Lung Cancer Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of ALK Positive Lung Cancer Treatment are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now